UBS Group’s Protolabs PRLB Stock Holding History

UBS Group’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-100	Closed	-$7K	–	9237
2014 Q4	$7K	Buy	+100	New	+$6.57K	﹤0.01%	8712

Other funds holding PRLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

UBS Group's PRLB Position: Q2 2026 in Review

UBS Group reduced its Protolabs (PRLB) stake by 42% in Q2 2026, selling an estimated $5.03M and leaving 97,304 shares worth $7.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3701.

UBS Group first reported a position in PRLB in Q4 2014 and has held it in 47 quarters since. The position peaked at $9.68M in Q2 2025. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

UBS Group held 97,304 shares of Protolabs worth $7.93M as of Q2 2026.
UBS Group sold 71,446 Protolabs shares in Q2 2026, an estimated $5.03M.
Protolabs made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3701 holding.
UBS Group first reported a position in Protolabs in Q4 2014 and has held it in 47 quarters since.
UBS Group's Protolabs position peaked at $9.68M in Q2 2025.
277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.